July 17, 2017
With the NASDAQ up all of the five (5) sessions last week and the IBB closing flat after 4 up days …
I’m nervous especially with forethcoming Q2 financial results, spending and cash positions
Investors should not dismiss the deviations of many pricing moves - we are always ready for the expected sector decline when this market “peters-out” which many expect.
A critical indication ahead of “our” universe’s open!
Pre-open indication: seven (7) with 5 BUY and 2 SELLs
This is a limited-time preview of RegMed Investor's morning call. To get the pre-open briefing, plus daily access of the happenings and realities of “our” universe ……SUBSCRIBE!
Don’t ignore this …
June 1, 2017
Calling out the recent 10-Q page 17’s paragraph re a 24 page legal filing - this is what BSTG did NOT want investors to know or read!
May 31, 2017
CYTX jumps +$0.04 or +4.08% to $1.01 with 113.05 shares traded – it’s still ONLY an OPTION - something is better than ... nothing!
January 28, 2017
What difference does a $1.00 subscription a day, $100.00 a quarter abating the lack of a portfolio ... enema!
July 14, 2017
The IBB was flat at 0.00%, IWM was up +0.22% with the XLV +0.67% while the VIX was down -3.43% along with the XBI -0.10% …
Read more because … unless you know what happened this week; it is hard to formulate a perspective for the next!
It’s called premium content for a reason … I define insight from a real-time perspective discussing equity share pricing, attractiveness and support levels as stock pricing changes by the hour … if not the minute!
Others don’t even come close!
Pre-open indication: six (6) - 5 hits and 1 misses
I answer one question, in which company should investors commit and keep their money.
June 27, 2017
On track for top-line 1 year powered data and potential BLA filing in Q3/18 BLA to the FDA shortly thereafter and, if approved, launching NeoCart in the second half of 2019
June 26, 2017
BLUE closed down -$4.20 to $1.06.90 after Monday's -$0.90 or -0.80% to $111.10
June 20, 2017
SGMO closes UP +$0.25 to $8.20 and promptly dives -$0.70 or -8.54% to $7.50 SGMO prices 10 M shares at $7.25
The process of calling out our grading of covered companies to rank and review the facts in evidence together with analysis, opinion and objective recommendation.